TARGET FOR IQ · CURRENT AFFAIRS
CCI Approves Rasmalai’s Proposed Stake Acquisition in Yatharth Hospital
Current affairs reading · 3 min read · English
On this page
What is the update?
The Competition Commission of India approved a proposed acquisition of certain shareholding in Yatharth Hospital & Trauma Care Services Limited by Rasmalai Limited. The announcement dated 14 November 2026 identified the parties and their business context without disclosing the precise stake or transaction value.
The two parties
| Party | Description in the announcement |
|---|---|
| Acquirer: Rasmalai Limited | An investment-holding entity incorporated in Cyprus. |
| Control of the acquirer | Indirectly controlled by investment funds managed or advised by Advent International, L.P. or its affiliates. |
| Target: Yatharth Hospital & Trauma Care Services Limited | Operates super-specialty hospitals in India, including healthcare, diagnostics and medical procedures. |
What CCI approved
The proposed combination concerned acquisition of shareholding in the target. The announcement did not say that Rasmalai was purchasing every share or acquiring all hospitals individually. Referring to it simply as a completed takeover would therefore go beyond the information provided.
Rasmalai was described as having no activities or presence in India at the time of the announcement. That statement concerns the acquirer as described in the release; it should not automatically be applied to every investment of the wider Advent-linked group.
Approval and completion are different
Competition approval concerns the proposed transaction placed before the regulator. It is distinct from evidence that the parties have completed all contractual steps and closed the investment. The short announcement reported approval and did not provide a closing date.
It also did not disclose the stake percentage, consideration paid, financing structure or any numerical market-share assessment. Those gaps should be preserved in an exam note rather than filled using assumptions about a typical hospital investment.
Why this belongs in current affairs
The update connects competition regulation, investment and healthcare services. In an institution-matching question, CCI is the relevant authority named in this approval, while Rasmalai is the acquirer and Yatharth is the target. Cyprus identifies the acquirer’s place of incorporation; it is not the location of the target’s hospital network.
For analytical revision, the example shows why the legal identity of an investor, its controlling funds and the operating business being invested in should be recorded separately. Regulatory clearance is also different from an investment recommendation or a prediction about hospital performance.
Exam revision
- Regulator: Competition Commission of India.
- Acquirer: Rasmalai Limited, incorporated in Cyprus.
- Target: Yatharth Hospital & Trauma Care Services Limited.
- The release did not disclose the exact shareholding percentage or transaction value.
Quick questions
Was the transaction value announced?
No transaction value was specified in this release.
Does approval alone prove that the investment has closed?
No. The announcement reported regulatory approval of the proposed combination, not its completion date.
Official references: Competition Commission of India — 2026-11-14.